Coronavirus Update - 21st May 2020

We understand our customers concerns relating to the spread of COVID-19 and would like to assure you that we are located in one of the least affected areas of the UK and are open for business as usual.

We can confirm that we have complied with the government's guidance on managing the risk of COVID-19.

Download the certificate here


Our work and case studies

Challenge: A client has developed new product to fulfil an unmet patient need. Pivotal clinical studies require highly sensitive, precise measurement of multiple insulin analogues from a small volume of plasma. Our existing methodologies have enabled successful proof of concept and non-regulated PK studies to be completed, but did not meet the precision necessary for regulatory acceptance. 


European Biotech Company 


Following a demonstration in the autumn, a new mass spectrometer was purchased, installed and verified for insulins analysis within four months, in time to meet the client’s timeline for a key clinical trial. Analysis for the trial commenced in the spring, and the system is now analysing samples around the clock. 

Analysis of Insulins Case Study